Vγ9Vδ2 T cell receptor–Butyrophilin-3A1 complex (Vγ9Vδ2 TCR–BTN3A1 complex)

The Vγ9Vδ2 T cell receptor–Butyrophilin-3A1 complex is a functional immunological unit critical in the activation of Vγ9Vδ2 T cells—an unconventional γδ T cell subset in humans. Vγ9Vδ2 T cells recognize changes in cell metabolism, notably the accumulation of phosphoantigens (microbial or tumor-derived), which are sensed by the intracellular B30.2 domain of the butyrophilin-3A1 (BTN3A1) molecule in the target cell. Upon binding phosphoantigens, BTN3A1 undergoes intracellular conformational changes, which are believed to be transmitted to its extracellular domains and, through interactions that may involve BTN2A1, become detectable by the Vγ9Vδ2 T cell receptor—thus initiating T cell activation. This pathway enables Vγ9Vδ2 T cells to rapidly identify and respond to infection and cancerous transformation. Targeting this complex has therapeutic potential for immuno-oncology and anti-infection strategies, though it carries risks of immune overactivation and specificity challenges.

Other names

Vgamma9Vdelta2 TCR–BTN3A1 complexVγ9Vδ2 TCR–BTN3A1 receptor complexVγ9Vδ2 T cell receptor–BTN3A1

Modulation of Vγ9Vδ2 T cell activation by inducing conformational change in BTN3A1 after phosphoantigen binding; Monoclonal antibodies can mimic or block this activation depending on epitope and binding site